Combination of axitinib and dasatinib for anti-cancer activities in two prostate cancer cell lines.

Autor: Nai-Xiong Peng1,2, Chun-Xiao Liu1 chunxiaoliu34@gmail.com, Xi-Sheng Wang2, Ze-Jian Zhang2, Su-Cai Liao2
Zdroj: Bangladesh Journal of Pharmacology. 2016, Vol. 11 Issue 1, p130-137. 8p.
Databáze: Academic Search Ultimate